FMI
HZNP

F/M Investments’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

F/M Investments’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,702
Closed -$249K – 102
2021
Q1 		$249K Sell
2,702
-34,068
-93% -$2.87M 0.2% 69
2020
Q4 		$2.69M Buy
+36,770
New +$2.73M 2.35% 14

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

F/M Investments's HZNP Position: Q2 2021 in Review

F/M Investments sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2021, closing a stake of 2,702 shares — an estimated $249K sold.

F/M Investments first reported a position in HZNP in Q4 2020 and held it in 2 quarters. The position peaked at $2.69M in Q4 2020. 526 funds tracked by Wall St. Rank hold HZNP as of Q2 2021.

  • F/M Investments reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2021 after selling out during the quarter.
  • F/M Investments sold 2,702 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2021, an estimated $249K.
  • F/M Investments first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 2 quarters.
  • F/M Investments's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $2.69M in Q4 2020.
  • 526 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2021.

Based on F/M Investments's 13F filing for Q2 2021, filed 10 Aug 2021.